作者: Marlen Knobloch , Christoph Dr. Esslinger , Kathrin Tissot , Christoph Prof. Hock , Roger Prof. Dr. Nitsch
DOI:
关键词:
摘要: Provided are novel specific binding molecules, particularly human antibodies as well fragments, derivatives and variants thereof that recognize neoepitopes of disease-associated proteins which derive from native endogenous but prevalent in the body a patient variant form and/or out their normal physiological context. In addition, pharmaceutical compositions comprising such mimics methods screening for may or not be targets treatment neurological disorders Alzheimer's disease described.